Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
Rhea-AI Summary
Cronos (NASDAQ: CRON, TSX: CRON) expanded its share repurchase flexibility by adding a TSX normal course issuer bid to its existing buyback program.
The company may repurchase up to US$50 million or 18,712,918 common shares (about 5.02% of shares) across U.S. and Canadian marketplaces through May 13, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- Authorization to repurchase up to US$50 million of common shares
- Buyback cap of 18,712,918 shares, about 5.02% of outstanding shares
- Ability to repurchase on both Nasdaq and TSX trading facilities
- OSC exemption enabling higher buyback limits on U.S. marketplaces
- Daily TSX buyback limit of 53,968 shares, 25% of average volume
Negative
- None.
News Market Reaction – CRON
On the day this news was published, CRON gained 2.69%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 11 | Brand share milestone | Positive | +0.4% | Spinach® vape portfolio became top-selling vape brand in Canada. |
| May 11 | Earnings and buyback | Positive | +8.3% | Strong Q1 2026 results and authorization of new $50M share repurchase. |
| May 06 | Product expansion | Positive | -0.4% | Expansion of Spinach STIX® cylindrical-style pre-rolls across Canada. |
| Apr 29 | Annual meeting notice | Neutral | -2.6% | Announcement of virtual-only 2026 annual shareholder meeting details. |
| Apr 20 | Earnings call notice | Neutral | +2.6% | Scheduling of Q1 2026 earnings conference call with management Q&A. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has generally been met with modestly positive or mixed reactions. Strong fundamental updates and brand milestones (Q1 earnings, Spinach® vape leadership) saw small to solid gains, while product launches and corporate process news produced smaller or even negative moves. This buyback extension follows a period where positive fundamentals and capital returns have not always translated into consistent upside, suggesting that investors have been selective in rewarding announcements.
Over the last few months, Cronos has highlighted several growth and corporate milestones. On Apr 20, it scheduled its Q1 2026 earnings call, followed by an announcement on Apr 29 of a virtual 2026 annual meeting. In early May, Cronos expanded its Spinach STIX® pre-roll portfolio, and on May 11 reported stronger Q1 2026 results plus a new $50 million share repurchase program. On Jun 11, Cronos celebrated Spinach® becoming Canada’s #1 vape brand. Today’s buyback-related news builds directly on that repurchase authorization.
Regulatory & Risk Context
Key Terms
normal course issuer bid regulatory
toronto stock exchange regulatory
nasdaq global market regulatory
public float financial
form 10-q regulatory
edgar regulatory
sedar+ regulatory
ncib exemption regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has filed with the Toronto Stock Exchange (the “TSX”), and the TSX has accepted, the Company’s notice of intention to make a normal course issuer bid (the “TSX NCIB”).
As previously announced by Cronos, the Company’s Board approved a share repurchase program on May 8, 2026, which commenced on May 14, 2026 and is expected to terminate on May 13, 2027, unless earlier terminated (the “Share Repurchase Program”). Pursuant to the TSX NCIB, repurchases under the Share Repurchase Program may now also be made from time to time pursuant to the facilities of the TSX and other alternative Canadian trading systems, in addition to being made through open market purchases at then-prevailing market prices through the facilities of the Nasdaq Global Market or other U.S. published markets, privately negotiated transactions or otherwise, as previously announced. Pursuant to the Share Purchase Agreement entered into on May 14, 2026, Celadon Financial Group, LLC has been appointed as the Company’s agent to repurchase shares on its behalf. Any such repurchases will be executed through Virtu Canada Corp. when made over the facilities of the TSX or other alternative Canadian trading systems
Pursuant to the Share Repurchase Program (including the TSX NCIB), Cronos intends to purchase for cancellation up to US
Under the TSX NCIB, Cronos may purchase up to 53,968 of its Common Shares on the TSX during any trading day, which represents
The TSX NCIB will be conducted in accordance with TSX rules and policies through the facilities of the TSX. The price that Cronos will pay for any Common Shares will be the market price prevailing at the time of purchase or such other price as may be permitted.
Additionally, on June 15, 2026, Cronos obtained an exemption order (the "NCIB Exemption") from the Ontario Securities Commission, permitting Cronos to make repurchases under the Share Repurchase Program through the facilities of the NASDAQ and other United States-based trading systems in excess of the maximum that would otherwise be allowable under applicable Canadian securities laws absent an exemption. The NCIB Exemption allows Cronos to repurchase on such U.S. marketplaces up to the greater of 5 percent of Cronos’s outstanding shares and 10 percent of Cronos' public float, provided that Cronos' aggregate repurchases on all marketplaces do not exceed this amount over the approximately 11-month period of the TSX NCIB, which is consistent with the maximum number of shares Cronos is able to purchase under the TSX NCIB. The other conditions to the NCIB Exemption will be outlined in Cronos' quarterly report on Form 10-Q for the quarter ended June 30, 2026 filed on EDGAR and SEDAR+.
About Cronos
Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS®, LIT™ and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Forward-Looking Information
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. The forward-looking information in this news release includes, but is not limited to, statements related to the Company’s intention to commence the TSX NCIB and the timing and quantity of any purchases of Common Shares under the TSX NCIB and the Share Repurchase Program. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, each of which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.
For further information, please contact:
Harrison Aaron
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com
